Patents Assigned to CoFix-RX, LLC
  • Nasal spray composition for COVID-19 and SARS and method of forming the same
    Patent number: 11439651
    Abstract: A nasal spray solution of the present invention includes a Povidone iodine solution; a Vitamin D liquid, Polysorbate 80 nf, Xylitol NF, water sterile, Sodium hydroxide 10% solution, and Polysaccharide 1% solution, wherein 1% solution further includes a gellan gum and a carrageenan, used as carriers to deliver liquids to cells of human and act as entrapment within a polymeric coating to block virus uptake into the cells, inactivate the virus, and protect a lining of an upper respiratory pathways against COVID-19 and SARS.
    Type: Grant
    Filed: July 13, 2021
    Date of Patent: September 13, 2022
    Assignee: CoFix-RX, LLC
    Inventors: Ravi Hedni, Karen Raehtz, Dennis G Kaiser, Andrew Krause
  • NASAL SPRAY COMPOSITION TO PREVENT COVID-19 AND SARS AND METHOD OF FORMING THE SAME
    Publication number: 20220117980
    Abstract: A nasal spray solution of the present invention includes a Povidone iodine solution; a Vitamin D liquid, Polysorbate 80 nf, Xylitol NF, water sterile, Sodium hydroxide 10% solution, and Polysaccharide 1% solution, wherein 1% solution further includes a gellan gum and a carrageenan, used as carriers to deliver liquids to cells of human and act as entrapment within a polymeric coating to block virus uptake into the cells, inactivate the virus, and protect a lining of an upper respiratory pathways against COVID-19 and SARS.
    Type: Application
    Filed: July 13, 2021
    Publication date: April 21, 2022
    Applicant: CoFix-RX, LLC
    Inventors: Ravi Hedni, Karen Raehtz, Dennis G. Kaiser, Andrew Krause